Latest news
-
Vertex ceases development of VX-522 inhaled RNA therapy for CF after stopping Phase 1/2 trial due to tolerability issues
Vertex has stopped a Phase 1/2 study of VX-522 inhaled RNA therapy for the treatment of cystic fibrosis and has ceased development of the product, the company said in its most recent report of financial… [Read more . . .]
-
Enterprise Therapeutics says Phase 2 trial of ETD001 inhaled ENaC blocker for CF met its primary endpoint
Enterprise Therapeutics announced that a Phase 2 trial of ETD001, an inhaled epithelial sodium channel blocker, met its primary endpoint, demonstrating a statistically significant and clinically relevant improvement in lung function versus placebo after 28… [Read more . . .]
-
Chance Pharma reports NMPA acceptance of NDA for CXG87 budesonide / formoterol DPI, Phase 3 results
According to Chance Pharmaceuticals, China’s National Medical Products Administration has accepted the company’s NDA for CXG87 budesonide / formoterol DPI for the treatment of asthma. The announcement emphasizes that the formulation is Chance’s own “improved… [Read more . . .]
-
Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations
CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing… [Read more . . .]
-
Intertek announces expansion of GMP stability storage facility
CDMO Intertek has announced an expansion of a GMP stability storage facility near Cambridge, UK, noting that the expanded facility offers custom temperature and relative humidity conditions and is suitable for stability testing of a… [Read more . . .]
Other recent news
-
RDD 2026 exhibitor preview
-
MannKind is developing ralinepag DPI (MNKD-1501) for United Therapeutics
-
Merxin receives King’s Award for Enterprise, names new Head of Business Development
-
Copley Scientific introduces new SRS 100i sample recovery system for inhaler testing
-
3P Innovation and Mikron Automation partner to offer DPI manufacturing systems
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
